We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > Heat Biologics

News List

Heat Biologics Enters into Research License Agreement for ProBioGen's Transposase System and Suspension HEK293 Cell Line b3cnewswire
July 14, 2021
ProBioGen announced today that they have entered into a research license agreement with Heat Biologics for both ProBioGen's Transposase System DirectedLuck™ as well as for their proprietary suspension HEK293 cell line.
No-one left behind: ensuring Covid-19 vaccines are effective in at-risk groups pharmaceutical-technology
June 19, 2020
Despite being most at risk from Covid-19, older people and those with compromised immune systems are unlikely to reap much benefit from Covid-19 vaccines, which are the main way we can overcome the viral pandemic.